Home
Conditions
Epilepsy

Clinical trial condition

Epilepsy

Explore clinical trials studying Epilepsy. Study availability and eligibility vary by location and protocol.

1,346 public trials 232 recruiting studies

Refine in advanced search Browse all conditions

Epilepsy trial results

Completed

Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine

NCT02281591

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsy, +1 more
Locations: Scope International Life Sciences AG, Hamburg, Germany

View Trial Details

Completed

A Study to Evaluate the Tolerability and Pharmacokinetics of Two Single and Multiple High Dose Regimens of BIA 2-093 In Healthy Volunteers

NCT01879345

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsy, +1 more
Locations: Human Pharmacology Unit - BIAL - Portela & Ca, S.A. Trofa, Coronado (S.Romão E S. Mamede), Portugal

View Trial Details

Completed

Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers

NCT01679002

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsy, +1 more
Locations: BIAL - Portela & Cª S.A. - Human Pharmacology Unit (UFH) S. Mamede Do Coronado, Trofa, Portugal

View Trial Details

Completed

Optimization of VNS in Epileptic Patients to Induce Cardioprotection

NCT04387435

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +10 more
Locations: UCLA Health Los Angeles, California, United States

View Trial Details

Completed

The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin

NCT02172742

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsy, +1 more
Locations: Human Pharmacology Unit (UFH)Section of Clinical Research (SIC), Department of Research & Development (DID), BIAL - Portela & Cª, SA, Trofa, Coronado (S.Romão E S. Mamede), Portugal

View Trial Details

Completed

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

NCT01228747

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsy, +6 more
Locations: 1 Beijing, China

9 Beijing, China

12 Changchun, China

19 Chengdu, China

View all 58 locations

View Trial Details

Completed

Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy

NCT00957047

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations: Bial - Portela & Cª, S.A. Trofa, Coronado (S.Romão E S. Mamede), Portugal

View Trial Details

Completed

Epileptic Activity in Patients With Alzheimer's Disease and Lewy Body Dementia

NCT04436341

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +12 more
Locations: Gunhild Waldemar Copenhagen, Copenhagen OE, Denmark

Troels Wesenberg Kjær Roskilde, Denmark

View Trial Details

Completed

The Evaluation of White Matter Intensities in Patients with Pediatric Epilepsy

NCT06887504

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsies, +6 more
Locations: Mersin University Mersin, Turkey, Turkey (Türkiye)

View Trial Details

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures

NCT00957684

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations: Bial - Portela & Cª, S.A. São Mamede do Coronado, Portugal

View Trial Details

Epilepsy

Epilepsy trial results

Related conditions